(Press-News.org) Genital herpes infections and their related complications lead to billions of dollars in health care expenditures and productivity losses globally, according to the first ever global estimates of the economic costs of these conditions.
The paper, which publishes July 1st in the journal BMC Global and Public Health, calls for greater investment in prevention of herpes transmission, including concerted efforts to develop effective vaccines against this common virus.
Corresponding author Nathorn Chaiyakunapruk, PharmD, PhD, professor of pharmacotherapy, and Haeseon Lee, PharmD, research fellow in pharmacotherapy, both at the College of Pharmacy of University of Utah Health, performed the research in collaboration with the World Health Organization and other academic institutions. They detail the associated economic cost estimates for genital herpes globally and by region.
Herpes is caused by infection with one of two types of the herpes simplex virus (HSV). Around two thirds of people (67%) aged 0-49 globally have HSV-1, according to the latest published statistics. It is mostly acquired in childhood, spreads by oral contact and causes infections in or around the mouth (oral herpes or cold sores). Adults can acquire genital HSV-1 infection through sexual contact if they were not infected during childhood. Type 2 spreads by sexual contact and causes genital herpes. Approximately 13% of the world’s population aged 15–49 years are living with HSV-2 infection.
In addition to sores and blisters, HSV can cause other more serious complications requiring healthcare attention, including a rare chance of mother to child transmission during childbirth, and increased risk of HIV infection.
More information on herpes: https://www.who.int/news-room/fact-sheets/detail/herpes-simplex-virus
Let’s Talk Herpes video explainer: https://www.youtube.com/watch?v=U_r36QCnTPY
END
Herpes infections take major economic toll globally, new research shows
2024-07-02
ELSE PRESS RELEASES FROM THIS DATE:
Tax on antibiotics could help tackle threat of drug-resistance
2024-07-02
Taxing certain antibiotics could help efforts to tackle the escalating threat of antibiotic resistance in humans, according to a new study by the University of East Anglia’s Centre for Competition Policy, Loughborough University and E.CA Economics.
Antimicrobial resistance (AMR) poses a significant global risk, causing an estimated 700,000 deaths annually. A key AMR report previously warned that if unchecked, it could endanger 10 million lives a year and result in $100 trillion in lost economic output ...
Organic material from Mars reveals the likely origin of life’s building blocks
2024-07-01
Organic material from Mars reveals the likely origin of life’s building blocks
Two samples from Mars together deliver the "smoking gun" in a new study showing the origin of Martian organic material. The study presents solid evidence for a prediction made over a decade ago by University of Copenhagen researchers that could be key to understanding how organic molecules, the foundation of life, were first formed here on Earth.
In a meteor crater on the red planet, a solitary robot is moving about. Right now it is probably collecting soil samples with a drill and a robotic arm, as it has quite ...
Light targets cells for death and triggers immune response with laser precision
2024-07-01
CHAMPAIGN, Ill. — A new method of precisely targeting troublesome cells for death using light could unlock new understanding of and treatments for cancer and inflammatory diseases, University of Illinois Urbana-Champaign researchers report.
Inflammatory cell death, knows as necroptosis, is an important regulatory tool in the body’s arsenal against disease. However, in some diseases, the process can go haywire; for example, cancer cells are able to suppress inflammatory signals and thus escape death.
“Usually treatments for cancer use pharmacological ...
Dr. Harish Manyam revolutionizes cardiac care with innovative device
2024-07-01
Harish Manyam, MD, is on a mission to improve the lives of people with heart problems. His recent accomplishment of implanting Tennessee’s first atrial leadless pacemaker is a step toward that, marking a significant advancement in cardiac care and promising safer and more effective treatment for patients.
The leadless pacemaker, in combination with a novel subcutaneous defibrillator, forms a groundbreaking system that addresses potentially dangerous problems associated with traditional pacemakers and defibrillators.
“This is a great leap forward for the field,” said Dr. Manyam, interim chair of the Department of Medicine at the ...
Want to stay mentally sharp longer? Eat a healthy diet now
2024-07-01
Chicago (July 1, 2024) — Eating a high-quality diet in youth and middle age could help keep your brain functioning well in your senior years, according to new preliminary findings from a study that used data collected from over 3,000 people followed for nearly seven decades.
The research adds to a growing body of evidence that a healthy diet could help ward off Alzheimer’s disease and age-related cognitive decline. Whereas most previous research on the topic has focused on eating habits of people in their 60s and 70s, the new study is the first to track diet and ...
Medication choice may affect weight gain when initiating antidepressant treatment
2024-07-01
Embargoed for release until 5:00 p.m. ET on Monday 1 July 2024
Annals of Internal Medicine Tip Sheet
@Annalsofim
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization ...
Weight change across common antidepressant medications
2024-07-01
Boston, MA – New evidence comparing weight gain under eight different first-line antidepressants finds that bupropion users are 15-20% less likely to gain a clinically significant amount of weight than users of sertraline, the most common medication.
The findings are published July 2 in Annals of Internal Medicine.
Antidepressants are among the most commonly prescribed medications in the U.S., with 14% of U.S. adults reporting using an antidepressant. Weight gain is a common side effect, which could affect patients’ long-term metabolic health and cause some to stop taking their prescribed treatment, leading ...
Dampening the "seeds" of hurricanes
2024-07-01
Dampening the "seeds" of hurricanes
Increased atmospheric moisture produced weaker hurricane formation
Increased atmospheric moisture may alter critical weather patterns over Africa, making it more difficult for the predecessors of many Atlantic hurricanes to form, according to a new study published this month.
The research team, led by scientists from the U.S. National Science Foundation National Center for Atmospheric Research (NSF NCAR), used an innovative model that allows for higher-resolution simulations of hurricane formation than ever before. This allowed researchers to study the effects of increased regional moisture over Africa, which is the birthplace of ...
Senescent cell-derived vaccines: A new concept towards an immune response against cancer and aging?
2024-07-01
“[...] cancer immunotherapy based on tumor-associated senescent cells and other types of senescent cells may achieve exciting outcomes beyond cancer therapy.”
BUFFALO, NY- July 1, 2024 – A new review paper was published on the cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 12, entitled, “Senescent cell-derived vaccines: a new concept towards an immune response against cancer and aging?”
Two recent seminal works have untangled the intricate role of tumor-associated senescent cells in cancer progression, or regression, by guiding our immune system against cancer ...
Danforth Plant Science Center President & CEO announces leadership transition plan
2024-07-01
ST. LOUIS, MO., July 1, 2024 – Today, Donald Danforth Plant Science Center President and CEO Jim Carrington, PhD, announced he will step down on July 1, 2025.
“I’ve been so fortunate to have had this opportunity over the past 13 years,” said Dr. Carrington. “We’ve been able to do so much because of our exceptional people, our partners and our supporters. But it’s time to plan for a transition, and I know the Center will benefit greatly from the renewal of perspective, ideas ...